2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)

C96H71N11O4Pt3 — CID 157269609

IUPAC2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)
SMILESC[N-]c1ccccc1-c1cc(-c2ccccc2)c2ccc3c(-c4ccccc4)cc(-c4ccccc4[N-]C)nc3c2n1.Oc1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1cn(-c2ccccc2)c(-c2nc(-c3ccccc3O)cn2-c2ccccc2)n1.[Pt+2].[Pt].[Pt]
InChIInChI=1S/C38H28N4.C30H22N4O2.C28H21N3O2.3Pt/c1-39-33-19-11-9-17-29(33)35-23-31(25-13-5-3-6-14-25)27-21-22-28-32(26-15-7-4-8-16-26)24-36(42-38(28)37(27)41-35)30-18-10-12-20-34(30)40-2;35-27-17-9-7-15-23(27)25-19-33(21-11-3-1-4-12-21)29(31-25)30-32-26(24-16-8-10-18-28(24)36)20-34(30)22-13-5-2-6-14-22;32-25-16-6-4-12-21(25)23-14-8-18-27(29-23)31(20-10-2-1-3-11-20)28-19-9-15-24(30-28)22-13-5-7-17-26(22)33;;;/h3-24H,1-2H3;1-20,35-36H;1-19,32-33H;;;/q-2;;;;;+2
InChIKeyXPNHQJUSIVAHEG-UHFFFAOYSA-N
MW2027.93 g/mol
LogP23.88
Rot. Bonds16

About 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)

2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) (PubChem CID 157269609) has the molecular formula C96H71N11O4Pt3 and a molecular weight of 2027.93 g/mol. Its IUPAC name is 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+).

Molecular Properties

Compound Name2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)
PubChem CID157269609
Molecular FormulaC96H71N11O4Pt3
Molecular Weight2027.93 g/mol
Exact Mass2026.46
IUPAC Name2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)
SMILESC[N-]c1ccccc1-c1cc(-c2ccccc2)c2ccc3c(-c4ccccc4)cc(-c4ccccc4[N-]C)nc3c2n1.Oc1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1cn(-c2ccccc2)c(-c2nc(-c3ccccc3O)cn2-c2ccccc2)n1.[Pt+2].[Pt].[Pt]
InChIInChI=1S/C38H28N4.C30H22N4O2.C28H21N3O2.3Pt/c1-39-33-19-11-9-17-29(33)35-23-31(25-13-5-3-6-14-25)27-21-22-28-32(26-15-7-4-8-16-26)24-36(42-38(28)37(27)41-35)30-18-10-12-20-34(30)40-2;35-27-17-9-7-15-23(27)25-19-33(21-11-3-1-4-12-21)29(31-25)30-32-26(24-16-8-10-18-28(24)36)20-34(30)22-13-5-2-6-14-22;32-25-16-6-4-12-21(25)23-14-8-18-27(29-23)31(20-10-2-1-3-11-20)28-19-9-15-24(30-28)22-13-5-7-17-26(22)33;;;/h3-24H,1-2H3;1-20,35-36H;1-19,32-33H;;;/q-2;;;;;+2
InChIKeyXPNHQJUSIVAHEG-UHFFFAOYSA-N
XLogP23.88
TPSA199.56 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds16
Heavy Atoms114
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002027.93
LogP ≤ 523.88
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-tert-butyl-N-[2-tert-butyl-5-(4-tert-butyl-2-pyridinyl)benzene-6-id-1-yl]-6-[10-(trifluoromethyl)benzo[g]quinazolin-4-yl]pyridin-2-amine;9-(4-tert-butyl-2-pyridinyl)-N-[3-[3-(2,6-diphenylphenyl)-2H-benzimidazol-3-ium-2-id-1-yl]benzene-2-id-1-yl]pyrido[2,3-b]indol-2-amine;2,4-ditert-butyl-6-[1-(4-tert-butyl-2-phenylphenyl)-4-[4-tert-butyl-6-[(4-phenyl-2-pyridinyl)amino]-2-pyridinyl]benzimidazol-2-yl]phenol;platinum;platinum(2+)
CID 157080983
CID 157462522
CID 157462522
CID 157617296
CID 157617296
CID 158157518
CID 158157518
CID 158239006
CID 158239006
CID 158431192
CID 158431192
CID 158636196
CID 158636196
CID 159096807
CID 159096807
2-[4-tert-butyl-6-[4-tert-butyl-6-(2-hydroxyphenyl)-2-pyridinyl]-2-pyridinyl]phenol;7,7-dimethyl-1,11-dihydrobenzo[a]phenalene-1,11-diide;3-(2,6-dimethylphenyl)-8-methyl-4-aza-1-azoniapentacyclo[13.2.1.04,17.05,10.011,16]octadeca-1(17),2,5(10),6,8,11,13,15-octaene;N,N-diphenyl-6H-pyrido[2,1-a]isoindol-5-ium-2-amine;bis(4-hydroxypent-3-en-2-one);tris(iridium);5-methyl-2-phenylpyridine;1-phenylisoquinoline;platinum;2-[4-(trifluoromethyl)benzene-6-id-1-yl]quinoline
CID 159471047
CID 159570252
CID 159570252
CID 159810756
CID 159810756
CID 159980703
CID 159980703

Frequently Asked Questions

What is the IUPAC name of 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)?
The IUPAC name of 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) (CID 157269609) is 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+).
What is the SMILES notation for 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)?
The canonical SMILES for 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) is C[N-]c1ccccc1-c1cc(-c2ccccc2)c2ccc3c(-c4ccccc4)cc(-c4ccccc4[N-]C)nc3c2n1.Oc1ccccc1-c1cccc(N(c2ccccc2)c2cccc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1cn(-c2ccccc2)c(-c2nc(-c3ccccc3O)cn2-c2ccccc2)n1.[Pt+2].[Pt].[Pt].
What is the InChIKey of 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)?
The InChIKey is XPNHQJUSIVAHEG-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H28N4.C30H22N4O2.C28H21N3O2.3Pt/c1-39-33-19-11-9-17-29(33)35-23-31(25-13-5-3-6-14-25)27-21-22-28-32(26-15-7-4-8-16-26)24-36(42-38(28)37(27)41-35)30-18-10-12-20-34(30)40-2;35-27-17-9-7-15-23(27)25-19-33(21-11-3-1-4-12-21)29(31-25)30-32-26(24-16-8-10-18-28(24)36)20-34(30)22-13-5-2-6-14-22;32-25-16-6-4-12-21(25)23-14-8-18-27(29-23)31(20-10-2-1-3-11-20)28-19-9-15-24(30-28)22-13-5-7-17-26(22)33;;;/h3-24H,1-2H3;1-20,35-36H;1-19,32-33H;;;/q-2;;;;;+2.
What are the key properties of 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+)?
2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) has a molecular weight of 2027.93 g/mol, XLogP of 23.88, 16 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[4-(2-hydroxyphenyl)-1-phenylimidazol-2-yl]-1-phenylimidazol-4-yl]phenol;2-[6-(N-[6-(2-hydroxyphenyl)-2-pyridinyl]anilino)-2-pyridinyl]phenol;methyl-[2-[9-(2-methylazanidylphenyl)-4,7-diphenyl-1,10-phenanthrolin-2-yl]phenyl]azanide;platinum;platinum(2+) is sourced from PubChem (CID 157269609), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).